TLR4 and early-onset autosomal dominant Alzheimer disease: AOS decrease the production of nitric oxide, prostaglandin E2, and pro-inflammatory cytokines, and block the expression of toll-like receptor 4 and nuclear factor (NF)-κB to prevent neuroinflammation or neurodegenerative diseases (such as Alzheimer’s disease; Zhou et al., 2015).